1Frye M A, HellemanG, McElroy S L, et al. Correlates of treat- mentemergent mania associated with antidepressant treatment inbipolar depression[J]. Am J Psychiatry, 2009, 166(2) : 164-172.
2Hausmann A, Hlrtnagl C, WalpothM, et al. Are there substantial reasons for contraindicating antidepressants inbipolar disorder part II: factsor ar-tefacts[J]. Neuropsychiatr, 2007, 21(2): 131-158.
3赵靖平,司天梅.精神病学[M].北京:人民卫生出版社,2009:583.
4Thase M E. Pharmacotherapy of bipolar depression: anupdate[J]. Curr Psychiatry Rep, 2006, 8(6): 478-488.
5Young L T, Joffe R T, Robb J C, et al. Double blind comparison of addition of a second mood stabilizer versus an antidepressants toan initial mood stabilizer for treatment of patients with bipolar depression[J]. Am J Psychiatry, 2000(157) : 124-126.
6Ghaemi S N, Gilmer W S, Goldberg J F, et al. Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study[J]. Clin Psychiatry, 2007 (68) : 1840-1844.
7ClaytonAH. Extended release bupropion: anant-idepressant with abroad spectrum of the rapeutie activity[J]. Expert Opin Pharma- tother, 2007, 8(4): 457-466.
9Lam R W, Hossie H, Solomons K, et al. Citalo-pramandbupmpion- SR: conbining versus switching in patients with treatment resistant depression[J]. JClinPsychiatry, 2004, 65(3): 337-340.
10Glod CA, Lynch A, Flynn E, et al. Open trial of bupropion SR in adolescent major depression[J]. Child Adolesc Psychiatr Nuts, 2003, 16(3): 123-130.
2Tomarken A J, Dichter GS, Freid C, et al. Assessing the effects of bupropion SR on mood dimensions of depression[J]. J Affect Disord, 2004, 78(3): 235.
3Glod CA, Lynch A, Flynn E, et al. Open trial of buprepion SR in adolescent major depression[J]. J Child Adolesc Psychiatr Nuts, 2003, 16 (3): 123.
4Jamerson BD, Krishnan KR, Roberts J, et al. Effect of bupropion SR on specific symptom clusters of depression: analysis tithe 31 - item Hamilton Rating Scale for depression [ J ]. Psychopharmacol Bull, 2003, 37 (2) : 67.
5Croft H, Houser TL, Jamerson BD, et al. Effect on body weight of bupropion sustained - release in patients with major depression treated for 52 weeks[J]. Clin Ther, 2002, 24(4): 662.
6Weihs KL, Honser TL, Batey SR, et al. Continuation phase treatment with buprepion SR effectivdy decreases the risk for relapse of depression [J]. Bid Psychiatry, 2002, 51 (9): 753.
7Nieuwstraten CE, Dolovich LR. Buprepion versus selective serotonin-reuptake inhibitors for treatment of depression[J]. Ann Pharmacother, 2001, 35(12): 1608.
8Settle EC, Stahl SM, Batey SR, et al. Safety profile of sustained-release buprepion in depression: results of three clinical trials[J]. Clin Ther, 1999, 21(3): 454.
9Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication [ J]. Arch Gen Psychiatry,, 2005,62(6) :617 - 627.
10Rush A J, Fava M, Wisniewski SR, et al. Sequenced treatment ahematives to relieve depression (STAR * D): rationale and design [ J ]. Control Clin Trials, 2004, 25 (1):119- 142.